reports personal fees from Public Health Advocacy Institute, CVS, Roth Capital Partners, Kantum Pharma, Mallinckrodt, Wolters Kluewer, GE Health Care, GSK, Allena Pharmaceuticals, Mass Medical International, Barron and Budd (versus Fresenius), JNJ, Venbio, Strataca, Takeda, Cerus, Pfizer, Bunch and James, Harvard Clinical Research Institute (also known as Baim Institute for Clinical Research), Oxidien, Sironax, Metro Biotechnology, Biomarin, Bain and Regeneron
KPV On 23 July 2026, PCAC voted to recommend adding KPV to the 503A Bulks List, in opposition to the FDA staff review, which had recommended against listing
Is Laser Skin Whitening a Better Option
The possibility that oxidized forms of ascorbate play signalling roles cannot be discounted (Xu et al
In one study, adults lost an average of 14.7% of their weight over 36 weeks
Sony Sherpa completed her MBBS at Guangzhou Medical University, China